Safety and efficacy of neurobloc™ (botulinum toxin type B) in type a responsive cervical dystonia patients

被引：0
|
作者：
Brashear, A
Lew, MF
Dykstra, DD
Comella, CL
Factor, SA
Rodnitzky, RL
Trosch, R
Singer, C
Brin, MF
Murray, JJ
Willmer-Hulme, A
Wallace, JD
Koller, M
机构：
来源：
NEUROLOGY | 1999年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A292 / A293
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia
    Brashear, A
    Lew, MF
    Dykstra, DD
    Comella, CL
    Factor, SA
    Rodnitzky, RL
    Trosch, R
    Singer, C
    Brin, MF
    Murray, JJ
    Wallace, JD
    Willmer-Hulme, A
    Koller, M
    [J]. NEUROLOGY, 1999, 53 (07) : 1439 - 1446
  • [2] Safety and efficacy of Neurobloc™ (botulinum toxin type B) in type a resistant cervical dystonia (CD) patients
    Brin, MF
    Lew, MF
    Adler, CH
    Comella, CL
    Factor, SA
    Jankovic, J
    O'Brien, CF
    Murray, JJ
    Wallace, JD
    Willmer-Hulme, A
    Koller, M
    [J]. NEUROLOGY, 1999, 52 (06) : A293 - A293
  • [3] Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia
    Brin, MF
    Lew, MF
    Adler, CH
    Comella, CL
    Factor, SA
    Jankovic, J
    O'Brien, C
    Murray, JJ
    Wallace, JD
    Willmer-Hulme, A
    Koller, M
    [J]. NEUROLOGY, 1999, 53 (07) : 1431 - 1438
  • [4] Efficacy and safety of repeated doses of botulinum toxin type B in type a resistant and responsive cervical dystonia
    Factor, SA
    Molho, ES
    Evans, S
    Feustel, PJ
    [J]. MOVEMENT DISORDERS, 2005, 20 (09) : 1152 - 1160
  • [5] Efficacy and safety of repeated doses of botulinum toxin type B in type a resistant and responsive cervical dystonia patients.
    Factor, SA
    Molho, ES
    Evans, S
    Feustel, PJ
    [J]. MOVEMENT DISORDERS, 2004, 19 (09) : 1122 - 1123
  • [6] Clinical experience with Neurobloc® (botulinum toxin type-B) in the treatment of patients with cervical dystonia, in Spain.
    Miquel, F
    Otermín, P
    Martí, J
    Blesa, D
    Chacón, J
    Aguilar, M
    Arbelo, J
    Vivancos, F
    Martinez, J
    Catalán, M
    López, J
    Campos, V
    Sanz, P
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R30 - R30
  • [7] Botulinum toxin type B for cervical dystonia
    Marques, Raquel E.
    Duarte, Goncalo S.
    Rodrigues, Filipe B.
    Castelao, Mafalda
    Ferreira, Joaquim
    Sampaio, Cristina
    Moore, A. Peter
    Costa, Joao
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (05):
  • [8] Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A
    Cardoso, F
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) : 607 - 610
  • [9] Comparison of the safety and efficacy of botulinum toxin type-A and anticholinergics in the treatment of cervical dystonia patients
    Relja, M.
    Bozikov, J.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S520 - S520
  • [10] Use of botulinum toxin type B (neurobloc) for segmental dystonia in a regional neurology centre
    Martin, S. -J.
    Newman, E. J.
    Grosset, K. A.
    Grosset, D. G.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S103 - S103
12345